Wednesday, 29 June 2022

 

 

LATEST NEWS Taliban-style murder rocks Udaipur, Chief Minister Ashok Gehlot appeals for peace Evidence of life on Mars may be over 6 feet deep : NASA Sidhu Moosewala murder : Special Cell arrests Lawrence Bishnoi aide in fresh case Himachal gets second state university in 52 years Biopic On Late Prime Minister Atal Bihari Vajpayee Announced, Planned To Release On Christmas 2023 Meta, Ministry of Tribal Affairs to digitally skill 10 lakh tribal youth Mukesh Ambani steps down from Reliance Jio, son Akash Ambani named Chairman Nagaland has potential of becoming organic hub of the country : Narendra Singh Tomar Punjab Assembly to bring resolution against Agnipath scheme Nushrratt Bharuccha’s Janhit Mein Jaari Remake In Punjabi? The Makers Announced It's Sequel Too No River Pollution To Be Allowed In Proposed Textile Park At Koom Kalan : Bhagwant Mann Sidhu Moosewala Becomes 3rd Most Searched Asians On Google In 2022. Complete List Inside Urvashi Rautela chuffed to be compared with the evergreen Rekha Sena 'family head' Uddhav Thackeray softens, urges rebels to return for talks Aamir Khan meets 'RRR' star Ram Charan at his Hyderabad home Mamata Banerjee alleges indirect pressure to give Agniveers jobs after 4 years Jos Buttler should be white-ball skipper and Test opener : Michael Vaughan Amruta Subhash-starrer web series 'Saas Bahu Aachar Pvt Ltd' releases on July 8 Randeep Hooda keeps his promise, performs last rites of Sarabjit Singh's sister Dalbir Kaur Chief Minister Jai Ram Thakur dedicates Sardar Patel University Mandi No river pollution will be allowed in proposed textile parks : Bhagwant Mann

 

From Vaccine to Vaccination

 Central Drugs Standard Control Organisation, CDSCO, Bharat Biotech, World Health Organization, WHO, Central Drugs Laboratory, Hyderabad, Coronavirus, COVID 19, Fight Against Corona, Covaxin, Covid-19 Vaccine, Oxygen, Oxygen Cylinders, SARS-CoV-2, Oxygen Plants, Oxygen Concentrator, Oxygen supply, Liquid Medical Oxygen

Web Admin

Web Admin

5 Dariya News

Hyderabad , 28 May 2021

 

The manufacturing, testing, release and distribution of vaccines is a complex and multifactorial process with hundreds of steps, requiring a diverse pool of human resources. For vaccines to result in actual vaccination of people, highly coordinated efforts are required from international supply chain, manufacturers, regulators and State and Central government agencies.Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP (Standard Operating Procedures of Good Manufacturing Practices). There is a four-month lag time for COVAXIN® to translate into actual vaccination.The timeline for manufacturing, testing and release for a batch of COVAXIN® is approximately 120 days, depending on the technology framework and regulatory guidelines to be met. Thus, production batches of COVAXIN® that were initiated during March this year will be ready for supply only during the month of June.Based on Central Drugs Standard Control Organisation(CDSCO) guidelines, all vaccines supplied in India are mandated by law to be submitted for testing and release to the Central Drugs Laboratory, Government of India. All batches of vaccines supplied to State and Central Governments are based on the allocation framework received from the Government of India.The timeline for vaccine supplies to reach the depots of the State and Central Governments from Bharat Biotech’s facilities is around two days. The vaccines received at these depots have to be further distributed by the State Governments to various districts within their respective states. This requires additional number of days. Pandemic vaccines are distributed by respective governments equitably across all sections of the population. Vaccines once available at the vaccination centers are then administered to recipients over a period of time, based on demand.

About Bharat Biotech

Bharat Biotech has established an excellent track record of innovation with more than 145 global patents, a wide product portfolio of more than 16 vaccines, 4 bio-therapeutics, registrations in more than 123 countries, and the World Health Organization (WHO) Pre-qualifications. Located in Genome Valley in Hyderabad, India, a hub for the global biotech industry, Bharat Biotech has built a world-class vaccine & bio-therapeutics, research & product development, Bio-Safety Level 3 manufacturing, and vaccine supply and distribution.Having delivered close to 5 billion doses of vaccines worldwide, Bharat Biotech continues to lead innovation and has developed vaccines for influenza H1N1, Rotavirus, Japanese Encephalitis (JENVAC®), Rabies, Chikungunya, Zika, Cholera, and the world’s first tetanus-toxoid conjugated vaccine for Typhoid. Bharat’s commitment to global social innovation programs and public-private partnerships resulted in introducing path-breaking WHO pre-qualified vaccines BIOPOLIO®, ROTAVAC®, and Typbar TCV® combatting polio, rotavirus, typhoid infections, respectively. The acquisition of Chiron Behring Vaccines, has positioned Bharat Biotech as the world's largest rabies vaccine manufacturer with Chirorab® and Indirab®.

 

Tags: Central Drugs Standard Control Organisation , CDSCO , Bharat Biotech , World Health Organization , WHO , Central Drugs Laboratory , Hyderabad , Coronavirus , COVID 19 , Fight Against Corona , Covaxin , Covid-19 Vaccine , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Oxygen Plants , Oxygen Concentrator , Oxygen supply , Liquid Medical Oxygen

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD